Dyadic gets Nasdaq deficiency notices on $1 minimum bid price and $35M MVLS; cure deadline March 24, 2027

DYADIC INTERNATIONAL INC

Notice dated September 25, 2026: Dyadic's common stock traded below the $1.00 minimum bid price for 30 consecutive business days, violating Nasdaq Listing Rule 5550(a)(2).
Separate notice: Market Value of Listed Securities fell below the $35 million minimum required by Nasdaq Listing Rule 5550(b)(2) for 30 consecutive business days.
Company has until March 24, 2027 to regain compliance by closing at $1.00+ and $35M+ MVLS for a minimum of 10 consecutive business days.
If not cured, Dyadic may qualify for a second 180-day period if it meets all other initial Nasdaq Capital Market standards, and could use a reverse stock split.
Nasdaq said it will issue a delisting notification if the deficiencies persist; Dyadic says it will monitor bid price and MVLS and evaluate options.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.